Larry Biegelsen
Stock Analyst at Wells Fargo
(3.77)
# 717
Out of 5,055 analysts
347
Total ratings
53.88%
Success rate
6.56%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Overweight | $452 → $456 | $362.22 | +25.89% | 17 | Nov 14, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $16 → $17 | $15.60 | +8.97% | 9 | Nov 14, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $103 → $95 | $85.09 | +11.65% | 12 | Nov 14, 2025 | |
| COO The Cooper Companies | Downgrades: Equal-Weight | $72 | $72.13 | -0.18% | 19 | Nov 13, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $131 → $114 | $107.00 | +6.54% | 7 | Nov 7, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $13 → $14 | $18.61 | -24.77% | 11 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Equal-Weight | $9 → $10 | $9.73 | +2.77% | 15 | Nov 6, 2025 | |
| INSP Inspire Medical Systems | Upgrades: Overweight | $101 → $90 | $86.35 | +4.23% | 14 | Nov 4, 2025 | |
| DXCM DexCom | Maintains: Overweight | $98 → $93 | $58.06 | +60.18% | 10 | Oct 31, 2025 | |
| GKOS Glaukos | Maintains: Overweight | $120 → $122 | $90.03 | +35.51% | 17 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $89 → $87 | $73.15 | +18.93% | 5 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $124 → $125 | $102.69 | +21.73% | 15 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $599 → $600 | $549.51 | +9.19% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $170 → $212 | $195.93 | +8.20% | 14 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $100 | $95.87 | +4.31% | 18 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $0.68 → $0.85 | $1.15 | -26.09% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $84 → $88 | $86.30 | +1.97% | 17 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Equal-Weight | $93 | $77.65 | +19.77% | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $3 | $1.49 | +101.34% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $18.47 | +29.94% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $315 → $290 | $280.07 | +3.55% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $11.32 | +28.09% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $27 | $24.98 | +8.09% | 2 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $113 → $98 | $89.91 | +9.00% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $12.94 | +31.38% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $11.77 | +316.31% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $130.59 | +4.14% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $84.45 | -17.11% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $193.04 | +39.87% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $53.01 | - | 2 | Nov 2, 2017 |
Stryker
Nov 14, 2025
Maintains: Overweight
Price Target: $452 → $456
Current: $362.22
Upside: +25.89%
Bausch + Lomb
Nov 14, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $15.60
Upside: +8.97%
Merit Medical Systems
Nov 14, 2025
Maintains: Overweight
Price Target: $103 → $95
Current: $85.09
Upside: +11.65%
The Cooper Companies
Nov 13, 2025
Downgrades: Equal-Weight
Price Target: $72
Current: $72.13
Upside: -0.18%
Teleflex
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $131 → $114
Current: $107.00
Upside: +6.54%
Tandem Diabetes Care
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $13 → $14
Current: $18.61
Upside: -24.77%
RxSight
Nov 6, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $9.73
Upside: +2.77%
Inspire Medical Systems
Nov 4, 2025
Upgrades: Overweight
Price Target: $101 → $90
Current: $86.35
Upside: +4.23%
DexCom
Oct 31, 2025
Maintains: Overweight
Price Target: $98 → $93
Current: $58.06
Upside: +60.18%
Glaukos
Oct 30, 2025
Maintains: Overweight
Price Target: $120 → $122
Current: $90.03
Upside: +35.51%
Oct 30, 2025
Maintains: Overweight
Price Target: $89 → $87
Current: $73.15
Upside: +18.93%
Oct 23, 2025
Maintains: Overweight
Price Target: $124 → $125
Current: $102.69
Upside: +21.73%
Oct 22, 2025
Maintains: Overweight
Price Target: $599 → $600
Current: $549.51
Upside: +9.19%
Oct 3, 2025
Upgrades: Overweight
Price Target: $170 → $212
Current: $195.93
Upside: +8.20%
Aug 20, 2025
Maintains: Overweight
Price Target: $98 → $100
Current: $95.87
Upside: +4.31%
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.15
Upside: -26.09%
Aug 7, 2025
Maintains: Overweight
Price Target: $84 → $88
Current: $86.30
Upside: +1.97%
Aug 6, 2025
Reinstates: Equal-Weight
Price Target: $93
Current: $77.65
Upside: +19.77%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.49
Upside: +101.34%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $18.47
Upside: +29.94%
Jul 30, 2025
Maintains: Overweight
Price Target: $315 → $290
Current: $280.07
Upside: +3.55%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $11.32
Upside: +28.09%
Jul 17, 2025
Maintains: Overweight
Price Target: $28 → $27
Current: $24.98
Upside: +8.09%
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $89.91
Upside: +9.00%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $12.94
Upside: +31.38%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $11.77
Upside: +316.31%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $130.59
Upside: +4.14%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $84.45
Upside: -17.11%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $193.04
Upside: +39.87%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $53.01
Upside: -